Replies to post #178704 on Biotech Values

[genisi]

Here is Yoram Gabison's comment (he is a respected reported who covers Teva for many years):

Teva unveils plan for separation of generic, specialty medicine units

http://www.haaretz.com/business/.premium-1.596806